Company
United StatesPublic company, NASDAQ: GRALGRAIL, Inc. (NASDAQ: GRAL), Menlo Park, CA – FDA Inspections
Inspection records and compliance data for GRAIL, Inc. in Menlo Park, CA. 1 FDA inspection on record, last inspected August 31, 2026. Publicly traded as NASDAQ: GRAL.
Company Profile
This profile covers GRAIL, Inc. based in Menlo Park, CA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 31, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 31, 2026 | Not classified | Medical Devices & Rad Health | 1335282 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
MRIMed Inc.
Delano Regional Medical Center
Mercy Imaging Ctrs a service of Dignity Hlth Med Foundation
Kaiser Foundation Hospital - Woodland Hills
High Desert Hospital
Redwood Regional Medical Group, Inc.
Sprig Oral Health Technologies, Inc.
Tustin Imaging Center
NeVap Inc.
Hill Street Imaging Medical Center
Company Information
Name
GRAIL, Inc.
Stock ticker
GRAL
Exchange
NASDAQ
Share price
$121.35
Market cap
$5.5B
Price as of
November 13, 2026
FEI Number
3013103906
Address
1525 O'Brien Drive, Menlo Park, CA 94025, United States
Country
United States
ID: b7b3f6e5-13db-48d7-bd02-6d8381993c30